Study Shows Importance of Cardiac Monitoring in High-Risk Breast Cancer Patients
MedPage Today,
While heart failure is an uncommon complication of breast cancer treatment, the risk may be higher in patients treated with…
While heart failure is an uncommon complication of breast cancer treatment, the risk may be higher in patients treated with…
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2018.
Here are what the editors at HealthDay consider to be the most important developments in Neurology for September 2018.
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for September 2018.
Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for September 2018.
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2018.
Here are what the editors at HealthDay consider to be the most important developments in Pathology for September 2018.
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for September 2018.
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for September 2018.
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for September 2018.
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2018.
FRIDAY, Sept. 28, 2018 -- More than half of physicians experience burnout, and many do not seek treatment for burnout…
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for September 2018.
Physicians Often Don't Address Their Burnout FRIDAY, Sept. 28, 2018 -- More than half of physicians experience burnout, and…
(HealthDay)—Risk of cardiotoxicity is higher for patients receiving trastuzumab and/or anthracyclines for the treatment of…
THURSDAY, Sept. 20, 2018 (HealthDay News) -- Risk of cardiotoxicity is higher for patients receiving trastuzumab and/or…
THURSDAY, Sept. 20, 2018 -- Risk of cardiotoxicity is higher for patients receiving trastuzumab and/or anthracyclines for the…
Advertisement 8.3% of the trastuzumab-treated patients developed heart failure vs 2.7% of patients who did not receive…